Literature DB >> 26701686

Endophthalmitis caused by Gram-positive organisms with reduced vancomycin susceptibility: literature review and options for treatment.

Nidhi Relhan1, Thomas A Albini1, Avinash Pathengay2, Ajay E Kuriyan1, Darlene Miller1, Harry W Flynn1.   

Abstract

BACKGROUND: Endophthalmitis caused by Gram-positive organisms with reduced vancomycin susceptibility and/or resistance is an important clinical issue worldwide.
PURPOSE: To review the published literature on endophthalmitis caused by Gram-positive organisms with reduced vancomycin susceptibility and/or vancomycin resistance.
METHODS: The data were analysed from a PubMed search of endophthalmitis cases caused by Gram-positive organisms with reported reduced vancomycin susceptibility and/or vancomycin resistance from 1990 to 2015.
RESULTS: From 18 publications identified, a total of 27 endophthalmitis cases caused by Gram-positive organisms with reduced vancomycin susceptibility and/or vancomycin resistance were identified. The aetiologies of endophthalmitis were exogenous in 19/27 cases (11 post-cataract surgery, 2 post-penetrating keratoplasty, 1 post-glaucoma surgery, 4 post-open globe injury, 1 post-intravitreal injection of ranibizumab), and endogenous in 4/24 cases; no details were available about the four remaining patients. The causative organisms included Enterococcus species (7/27), coagulase-negative staphylococci (4/27), Staphylococcus aureus (4/27), Bacillus species (4/27), Streptococcus species (3/27), Leuconostoc species (3/27), Staphylococcus hominis (1/27), and unidentified Gram-positive cocci (1/27). Visual acuity of 20/400 or better at the final follow-up was recorded in 10/26 patients (38.5%; data were not available for one patient). Treatment options include fluoroquinolones, penicillin, cephalosporins, tetracyclines, and oxazolidinones.
CONCLUSIONS: In the current study, visual acuity outcomes were generally poor. Enterococcus and Staphylococcus species were the most common organisms reported and postoperative endophthalmitis after cataract surgery was the most common clinical setting. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Entities:  

Keywords:  Eye (Globe); Infection; Microbiology; Retina; Vitreous

Mesh:

Substances:

Year:  2015        PMID: 26701686      PMCID: PMC5541392          DOI: 10.1136/bjophthalmol-2015-307722

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  70 in total

1.  Pharmacokinetics of intravenously administered tigecycline in eye compartments: an experimental study.

Authors:  Muammer Ozcimen; Yasar Sakarya; Serap Ozcimen; Sertan Goktas; Rabia Sakarya; Ismail Alpfidan; Erkan Erdogan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-08-23       Impact factor: 3.117

2.  Postoperative vancomycin-resistant Enterococcus faecium endophthalmitis.

Authors:  Harshivinderjit S Bains; David V Weinberg; Robert S Feder; Gary A Noskin
Journal:  Arch Ophthalmol       Date:  2007-09

3.  Vancomycin-resistant coagulase negative Staphylococcus endophthalmitis following cataract surgery.

Authors:  Manmath K Das; Avinash Pathengay; Gaurav Y Shah; Nagendra K Koday
Journal:  J Cataract Refract Surg       Date:  2011-10       Impact factor: 3.351

Review 4.  Vancomycin resistance in ocular infections.

Authors:  Meenakashi Gupta; Marlene L Durand; Lucia Sobrin
Journal:  Int Ophthalmol Clin       Date:  2011

5.  Quinupristin/dalfopristin in vancomycin-resistant Staphylococcus aureus endophthalmitis.

Authors:  Edward M Stroh
Journal:  Arch Ophthalmol       Date:  2012-10

6.  New therapy option for treatment of methicillin-resistant Staphylococcus aureus keratitis: tigecycline.

Authors:  Sertan Goktas; Muhammet Guzel Kurtoglu; Yasar Sakarya; Ceyhan Ugurluoglu; Muammer Ozcimen; Rabia Sakarya; Ismail Alpfidan; Ismail Senol Ivacık; Erkan Erdogan; Abdulkadir Bukus
Journal:  J Ocul Pharmacol Ther       Date:  2014-10-20       Impact factor: 2.671

7.  Vancomycin-resistant Streptococcaceae from clinical material.

Authors:  R Lütticken; G Kunstmann
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1988-01

8.  Intracameral vancomycin following cataract surgery: An eleven-year study.

Authors:  Deepa R Anijeet; Prasad Palimar; Clive O Peckar
Journal:  Clin Ophthalmol       Date:  2010-04-26

9.  Quinupristin/dalfopristin in Staphylococcus aureus endophthalmitis: a case report.

Authors:  Sergio E Hernandez-Da Mota
Journal:  J Med Case Rep       Date:  2011-03-31

10.  Intravitreal moxifloxacin in the management of Ochrobactrum intermedium endophthalmitis due to metallic intraocular foreign body.

Authors:  David J Jacobs; Thomas J Grube; Harry W Flynn; Craig M Greven; Avinash Pathengay; Darlene Miller; Robert F Sanke; Joseph Thorman
Journal:  Clin Ophthalmol       Date:  2013-08-27
View more
  18 in total

1.  The Susceptibility of Bacterial Endophthalmitis Isolates to Vancomycin, Ceftazidime, and Amikacin: a 23 Year-Review.

Authors:  Shilpa Kodati; Andrew W Eller; Regis P Kowalski
Journal:  Ophthalmol Retina       Date:  2017 May-Jun

2.  Emerging Worldwide Antimicrobial Resistance, Antibiotic Stewardship and Alternative Intravitreal Agents for the Treatment of Endophthalmitis.

Authors:  Nidhi Relhan; Avinash Pathengay; Stephen G Schwartz; Harry W Flynn
Journal:  Retina       Date:  2017-05       Impact factor: 4.256

Review 3.  Modeling intraocular bacterial infections.

Authors:  Roger A Astley; Phillip S Coburn; Salai Madhumathi Parkunan; Michelle C Callegan
Journal:  Prog Retin Eye Res       Date:  2016-05-03       Impact factor: 21.198

Review 4.  Endophthalmitis: Then and Now.

Authors:  Nidhi Relhan; Richard K Forster; Harry W Flynn
Journal:  Am J Ophthalmol       Date:  2017-12-05       Impact factor: 5.258

5.  Acute-onset endophthalmitis caused by Staphylococcus lugdunensis.

Authors:  Robert B Garoon; Darlene Miller; Harry W Flynn
Journal:  Am J Ophthalmol Case Rep       Date:  2017-12-24

6.  Isolation and determination of four potential antimicrobial components from Pseudomonas aeruginosa extracts.

Authors:  Ling-Qing Xu; Jian-Wen Zeng; Chong-He Jiang; Huan Wang; Yu-Zhen Li; Wei-Hong Wen; Jie-Hua Li; Feng Wang; Wei-Jen Ting; Zi-Yong Sun; Chih-Yang Huang
Journal:  Int J Med Sci       Date:  2017-11-02       Impact factor: 3.738

7.  Update on the Epidemiology and Antibiotic Resistance of Ocular Infections.

Authors:  Darlene Miller
Journal:  Middle East Afr J Ophthalmol       Date:  2017 Jan-Mar

8.  The trend of resistance to antibiotics for ocular infection of Staphylococcus aureus, coagulase-negative staphylococci, and Corynebacterium compared with 10-years previous: A retrospective observational study.

Authors:  Hideto Deguchi; Koji Kitazawa; Kanae Kayukawa; Eri Kondoh; Akiko Fukumoto; Toshihide Yamasaki; Shigeru Kinoshita; Chie Sotozono
Journal:  PLoS One       Date:  2018-09-07       Impact factor: 3.240

9.  Endophthalmitis caused by gram-positive bacteria resistant to vancomycin: Clinical settings, causative organisms, antimicrobial susceptibilities, and treatment outcomes.

Authors:  Hegde Sharat Shivaramaiah; Nidhi Relhan; Avinash Pathengay; Nitin Mohan; Harry W Flynn
Journal:  Am J Ophthalmol Case Rep       Date:  2018-02-28

10.  Preparation and in vivo evaluation of nanoliposomes containing vancomycin after intravitreal injection in albino rabbits.

Authors:  Majid Abrishami; Mehrdad Motamed Shariati; Bizhan Malaekeh-Nikouei; Amineh Sadat Tajani; Asma Mahmoudi; Mojtaba Abrishami; Bahman Khameneh
Journal:  Iran J Basic Med Sci       Date:  2020-04       Impact factor: 2.699

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.